SCHEMBL4981682

SCHEMBL4981682

CCCNc1ccc2c(c1)Cc1cc(NC(=O)O)ccc1-2

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.60
NPC1 O15118 1/20 0.56
POLB P06746 1/20 0.55
KMT2A Q03164 2/20 0.52
CYP1A2 P05177 3/20 0.50
ADRA2A P08913 1/20 0.50
MAOA P21397 1/20 0.50
SLC6A2 P23975 1/20 0.50
HTR2C P28335 1/20 0.50
SLC6A4 P31645 1/20 0.50
HTR2B P41595 1/20 0.50
SLC1A3 P43003 5/20 0.46
SLC1A2 P43004 5/20 0.46
SLC1A1 P43005 5/20 0.46
MEN1 O00255 1/20 0.44
KDM4E B2RXH2 2/20 0.44
CYP2C9 P11712 2/20 0.44
MAPT P10636 2/20 0.44
TSHR P16473 1/20 0.44
ALDH1A1 P00352 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3979949 0.82 RAB9A (0.52) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL3977311 0.82 RAB9A (0.51) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL14186880 0.78 RAB9A (0.49) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL3981682 0.76 RAB9A (0.45) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL21765857 0.75 RAB9A (1.00) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL1931259 0.75 ABL1 (0.50) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL4984937 0.75 RAB9A (0.50) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL3977137 0.74 RAB9A (0.49) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL2962505 0.73 MAOA (0.84) RAB9ANPC1POLBKMT2ACYP1A2
SCHEMBL27754695 0.72 CYP1A2 (0.54) RAB9ANPC1POLBKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080113975-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-05-15 US disclosed
US-20080096875-A1 THIOUREA COMPOUNDS NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2008-04-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096875-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, ETV6 RAB9A 2434/4885NPC1 1677/4885POLB 3499/4885
US-20080113975-A1 THIOUREA COMPOUNDS TPMT, HAVCR2, EIF2AK2 RAB9A 2430/4885NPC1 1372/4885POLB 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.